The Toxicologist - Society of Toxicology

More documents

Recommendations

Info

AUTHOR INDEX Author Index (Continued) Williams, L ....................................... 1675* Williams, M A .................................... 673* Williams, N ........................................ 2171 Williams, P L ........................................ 984 Williams, R .................. 1215, 1438, 1615* Williams, S ................................... 295, 296 Willis, D N ......................................... 574* Willoughby, J ..................................... 2544 Wills, L P ............................................ 751* Wills, L ................................................. 318 Wills, R .............................................. 2113 Willson, G A ............................... 601, 1951 Willy, J A .......................................... 1902* Wilson, A ............................................ 727* Wilson, C L ........................................ 1224 Wilson, C R ........................................ 2428 Wilson, C ......................................... 2223* Wilson, D ................................. 1322, 1517 Wilson, H ............................................. 955 Wilson, M J ...................................... 1419* Wilson, M ......................................... 2415* Wilson, N ........................................... 1572 Wilson, V S ............ 16*, 1023, 2303, 2663 Wilson, V ........................................... 1022 Wilt, N ............................ 1551, 2555, 2564 Wiltshire, T......................................... 962* Wimmer, J .......................................... 1233 Winans, B ............................... 2662, 2666* Wincent, E .............................. 1839, 1845* Wind, M .......................... 418, 1518, 1519, 1520, 1553 Winder, B S ........................................ 2088 Wingard, C J............................... 193, 1186 Wingfield, M ...................................... 1233 Winitthana, T ...................................... 1842 Winnik, W .......................................... 2159 Winsett, D W ........................ 570, 607, 608 Winters, J.............................................. 323 Wiriyachan, N .................................... 2638 Wirth, J R ........................................... 658* Wirth, M ............................................... 745 Wise Jr., J P ........................................ 280* Wise Sr., J P.......................................... 280 Wise, A ............................................... 2360 Wise, C F ................................ 2342*, 2392 Wise, J P .............. 278, 279, 282, 303, 304, 1870, 2164, 2341, 2342, 2342, 2392, 2392, 2405, 2407 Wise, J ............................ 303, 2341*, 2392 Wise, K ............................................... 1957 Wise, S S ........................... 278, 279, 2342, 2392*, 2405 Wise, S ..................................... 2341, 2407 Wise, Sr., J P....................................... 2252 Wisler, J .............................................. 244* Witriol, A M ....................................... 1755 Witt, K L ............................ 323, 493, 2501 Wittern, K ............................................. 967 Witzmann, F A ....................................... 10 Wiwatratana, D .................................. 1344 Wnek, S M ............................. 1677, 1976* Wogan, G N.............................. 1408, 2642 Wohlleben, W ........................... 1458, 1798 Wohlman, I M .................................. 2028* Wolansky, M J ................ 1227, 1346, 2262 Wolf, A ............................ 430, 1092, 1107, 1436, 1603, 1766*, 2537 Wolf, C J ................................ 2240*, 2306 Wolf, D C ............................... 1718*, 2645 Wolf, D ................................................. 367 Wolf, M ................................................ 158 Wolfarth, M G ............................ 53*, 1454 Wolfarth, M .....................1178, 1185, 2325 Wolfinger, R D ........................... 725, 1604 Wolterbeek, A ........................... 630*, 2613 Wolthoorn, J ..............................1150, 1151 Womack, T L ...................................... 2653 Wong, B A ............ 290, 1570*, 1953, 1954 Wong, J............................................... 118* Wong, S ................................................ 775 604 SOT 2011 ANNUAL MEETING Wong, V A ............................................ 601 Woo, L L........................................... 2642* Wood, A ...................................... 223, 2639 Wood, C R ................................ 1609, 2239 Wood, J............................................. 1438* Woodahl, E L ..................................... 2265 Woodin, B .......................................... 1840 Woodruff, R S .................................... 2077 Woodruff, T J ..................................... 2360 Woods, C G .................... 366*, 2001, 2502 Woods, J S .......................................... 610* Woods, R ............................................ 1771 Woods, S E ......................................... 2582 Woodward, A ...................................... 2589 Woodward, R A .................................. 2656 Worden, M ......................................... 1463 Workman, H C ............... 536*, 1502, 1503 Worley, R R .......................................... 731 Wormser, U ............................ 1207, 2205* Worth, A ............................................... 483 Wourms, M J .................................... 1121* Wouters, D ......................................... 1150 Woutersen, R A .................................... 991 Wrench, N .............................. 1022, 1023* Wright, D.............................................1115 Wright, F .............................................. 981 Wright, J M ........................................ 1810 Wright, J ........ 874, 875, 1030, 1589, 2266, 2616* Wright, P F ....................................... 2179* Wright, R ............................................ 1238 Wrobel, J .............................................. 260 Wruck, C J .......................................... 1002 Wu, A ......................................... 542, 1427 Wu, C ..................................... 1485*, 2177 Wu, D ................................................. 1130 Wu, F .................................................. 2153 Wu, H ................................. 299, 300, 1665 Wu, J .................................................... 118 Wu, K C ........................................... 2503* Wu, M ................................................ 992* Wu, N ....................................... 1178, 1454 Wu, P ........................................ 1460, 2065 Wu, Q ......... 301*, 379*, 2004, 2005, 2006 Wu, T .......................................... 413, 1997 Wu, X ............................................... 1830* Wu, Y ................................................. 1234 Wu, Z.................................................. 1459 Wurzburger, L .................................. 2564* Wyde, M E ......................................... 2234 Wyde, M ............................................. 2627 Wynder, J.......................................... 2371* Wynne, R ............................................ 1302 Wyrobek, A J ........................................ 337 X Xanthi, C ............................................ 1856 Xi, C ................................................... 2563 Xia, M ........................ 482, 493, 981, 2501 Xia, Q ..................................................... 67 Xia, X ............................1174*, 1176, 2154 Xia, Y ............................... 76, 1053*, 2367 Xiang, Z ............................................... 558 Xiangrong, L ...................................... 2231 Xiao, R ............................................. 1627* Xiao, S................................................ 1025 Xiao, Y Q ........................................... 1929 Xie, F................................ 538, 582, 2319* Xie, G ................................................. 2148 Xie, H ............ 279, 303, 304, 2164*, 2341, 2342, 2405 Xie, J .................................................. 1224 Xie, R ................................................. 1672 Xie, W ................................................ 376* Xie, Y ............................................... 2171* Xing, C ................................................. 337 Xiong, J Q ................................ 1067, 2057 Xu, B .................................................... 200 Xu, F .................................................. 1904 Xu, H .................................................. 1561 The numerals following the author’s names refer to the abstract numbers. The asterisk after the abstract number indicates the author is the fi rst presenter. Xu, J ............ 133, 414, 1079, 1862, 2139*, 2140, 2270, 2499, 2586*, 2592 Xu, L ........................................ 2074, 2367 Xu, P ................................................... 1199 Xu, X ................................ 987, 2323, 2344 Xu, Y .. 206, 214*, 331, 342*, 1918, 1992* Xue, P ..................................... 2001*, 2502 Xue, S ......................... 183, 209, 984, 2204 Y Yacovino, L ...................................... 1058* Yadav, A ............................................. 2335 Yadav, B D ............................. 2634, 2635* Yafawi, R...................................... 528, 530 Yagi, M ................................................. 649 Yahata, Y ............................................ 1211 Yakabe, Y ........................................... 1598 Yalcin, M ............................................ 1389 Yamada, H ............................ 124, 139, 436 Yamada, K E ...................................... 408* Yamada, M ............................... 1403, 1404 Yamada, T ............................ 321, 425, 436 Yamada, Y ............................................ 175 Yamaguchi, T ....................................... 175 Yamamoto, C........................................ 412 Yamamoto, M .................412, 1113, 1787*, 2499, 2586 Yamamoto, S ........................................ 687 Yamamoto, T ...................................... 2619 Yamashita, K ................ 1494, 2084, 2085* Yamazaki, K ....................................... 1547 Yamazaki, M ........................................ 438 Yamazaki, S.......................................... 804 Yamazoe, Y .......................................... 532 Yan, C ....................................... 626, 1663* Yan, J ............................ 1429, 2004, 2077* Yan, S ................................................. 2365 Yan, Y ................................................. 1775 Yan, Z ............................................... 2089* Yanagiba, Y ................................ 515, 1490 Yanamala, N ........................................... 54 Yang, C Z ................................. 624, 2429* Yang, C ...................... 155, 158, 469*, 492, 495, 1016 Yang, D .................................. 2623, 2624* Yang, F ..................................... 478*, 2136 Yang, G ................................................ 377 Yang, H M .......................................... 2307 Yang, H .................. 370, 589, 1449, 1480* Yang, J ................. 684*, 987*, 1294, 1890, 2209, 2218, 2525, 2536 Yang, L ................... 127, 880*, 2039, 2220 Yang, Q .............................................. 381* Yang, S ....................... 1399*, 1461, 1483* Yang, T ............................................... 1166 Yang, W ...................................... 230, 2073 Yang, X ................. 432, 454*, 1561, 1678, 1847, 2174 Yang, Y ........ 299, 300, 479, 589, 876, 940, 941*, 1592, 1665*, 1735, 1853, 1900 Yaniger, S ............................................. 624 Yano, T ............................................... 1969 Yanochko, G ....................................... 1821 Yanova, N ............................................. 104 Yao, P ................................... 66*, 70, 1657 Yao, Y ............................... 207, 230*, 2073 Yaqoob, N .......................................... 1685 Yarborough, K M ................................. 366 Yassine, H N....................................... 1281 Yasuda, M ............................................ 508 Yasui, K ............................................ 1571* Yasui, Y .............................................. 1404 Yasutake, A ........................................... 266 Ye, L ................................................... 492* Ye, X ................................................ 1025* Yeager, R .................................... 507*, 518 Yeatts, J ................................................ 642 Yedjou, C G .................... 338, 1223, 1887* Yellowhair, M ..................................... 283* Yen, C ............... 299, 300, 307, 1393, 1998 Yeow, A .............................................. 2009 Yesupriya, A ....................................... 1204 Yi, J .................................................... 1471 Yin, Z ............................................... 2636* Ying, X ............................................... 1322 Yli-Pirilä, P .......................................... 672 Yokel, R A .............................. 1460*, 2065 Yokley, K A ........................................ 2307 Yokohira, M ............................. 232*, 2646 Yokoi, T ............................ 428*, 510, 2079 Yong, K Y ........................................... 1274 Yoo, S ................... 1825, 1826, 1827, 1844 Yoon, H .............................................. 1016 Yoon, M.................. 701*, 941, 2141, 2459 Yoshida, M ....................... 627, 1090, 2657 Yoshida, T ............ 902, 907*, 2080*, 2083 Yoshida, Y .......................................... 1177 Yoshikawa, T ....... 1494, 2080, 2083, 2084, 2085 Yoshikawa, Y ....................................... 428 Yoshioka, N ...................................... 2302* Yoshioka, Y .... 1494*, 2080, 2083, 2084, 2 085 Yost, G S .............. 886*, 1848, 2333, 2334 You, C H............................................. 1256 Young, D ............................................ 2245 Young, J................................................ 969 Young, M.......................................... 1368* Young, S H ........... 1189, 1462, 1492, 2072 Young, S .......... 337, 659, 670, 1459, 1759, 2318, 2325* Younis, H S ........................................ 216* Yourick, D ...................... 2020, 2037, 2039 Yourick, J J ......................................... 890* Yu, H ........................................ 588*, 1561 Yu, I ........................................ 1762*, 1763 Yu, J C .................................... 1689*, 2046 Yu, L ............................... 995, 1070, 1291* Yu, S D ............................................... 1256 Yu, S ..................................................... 628 Yu, X .........................................2111, 2520 Yu, Y................................................... 2128 Yu, ........................................................ 553 Yuan, J .................................... 1364*, 2697 Yuan, Y ..................................... 1344, 1397 Yucesoy, B .................................. 97, 1367* Yudate, H T .......................................... 436 Yum, Y ............................................. 2536* Yun, H .................................... 2054, 2208* Yurdagul, A ........................................ 1320 Yuspa, S H ........................................ 1781* Z Zablotsky, J .......................................... 931 Zacharewski, T R ...........917*, 1039, 1115, 1584, 1597, 2305, 2549 Zacur, H.............................................. 1219 Zadworny, M ...................................... 1465 Zaffo, B J................................ 1388, 1389* Zahalka, E A ....................................... 2654 Zahran, E ............................................ 2250 Zaikova, T .......................................... 1479 Zaja-Milatovic, S ............................... 2128 Zakeri, Z ............................................. 1272 Zakharov, A D .................................... 1885 Zaldívar Comenges, J ........................... 733 Zalups, R K .......................................... 761 Zamurovic, N ..................................... 1436 Zandbergen, F J ................................ 2366* Zandstra, P ......................................... 1888 Zangar, R .......................................... 1287* Zanoncelli, S ...................................... 1045 Zanoni, M B ........... 336, 1418, 2408, 2409 Zanoni, T B ...................................... 2408* Zarbl, H ........ 40*, 953, 1702*, 1708, 2647 Zaroogian, G ...................................... 2384 Zavala, J ............................................. 2332 Zavecz, J H ........................................... 209 Zawia, N H ......................................... 2187 Zawia, N ........................................... 1700* Zayed, J .............................................. 2487 Zefirov, N S .......................................... 861
Author Index (Continued) The numerals following the author’s names refer to the abstract numbers. The asterisk after the abstract number indicates the author is the fi rst presenter. Zehnacker, C ...................................... 2537 Zehr, R D ............................................ 1622 Zeidler-Erdely, P C ............ 185, 563, 1492, 2322* Zeiger, E ....................................... 332, 486 Zeise, L ................. 472, 1962*, 1967, 2360 Zelikoff, J T ......................... 22, 666, 1067, 1069, 2057 Zeller, M ........................................... 2695* Zellner, D ......................................... 2628* Zenick, H ............................................ 908* Zezzi-A, M A ..................................... 2434 Zgoda-Pols, J R .................................... 745 Zhai, Y .................................................. 376 Zhan, L ............................................... 207* Zhan, Q .............................................. 2275 Zhang, B ................................... 260, 1495* Zhang, C ........................... 384, 395, 2593* Zhang, D D ................. 1278, 1786*, 1791* Zhang, F ......................... 486, 753*, 2383* Zhang, H .......................................... 1488* Zhang, J ......... 213, 934, 1085, 1279, 1452, 1549*, 2142, 2144*, 2490, 2598 Zhang, K .............................................. 772 Zhang, L W ...................................... 1175* Zhang, L .............. 76, 143, 176, 337, 494*, 817, 947, 1831, 2074, 2347, 2558 Zhang, M .................................... 138*, 934 Zhang, Q ......... 117, 609, 744, 754, 1434*, 1463, 2001, 2488 Zhang, R ........................................... 2246* Zhang, T ............................................. 2136 Zhang, W ............................................ 2344 Zhang, X Y ......................................... 2136 Zhang, X ..................... 723*, 1239, 1283*, 1284, 1359, 1450, 1505*, 1651*, 1661*, 2313*, 2596, 2597, 2647 Zhang, Y J ........................................ 1104* Zhang, Y ................ 449, 548, 2137, 2174*, 2220, 2606 Zhao, B ............................. 954, 1105, 2078 Zhao, C Y ........................................... 2136 Zhao, D .............................................. 518* Zhao, F ............................. 413, 1025, 2447 Zhao, G ................................................ 465 Zhao, P ............................................... 1359 Zhao, R ............................................. 2502* Zhao, Y ................................... 219*, 1664* Zhao, Z ............................................... 2576 Zheng, G .......................................... 2122* Zheng, J ...................................... 236, 1860 Zheng, R ............................................. 637* Zheng, W ........... 1377, 1896*, 2122, 2136, 2137, 2138*, 2139, 2140, 2144, 2592 Zheng, X ................................ 1677*, 1976 Zheng, Y ............................................. 1359 Zhong, H ............................................ 2002 Zhong, Q .............................................. 752 Zhong, W ............................................. 877 Zhongxian, G ....................................... 774 Zhou, A ............................................... 1234 Zhou, B ................................................ 945 Zhou, G .............................................. 1856 Zhou, H .......................... 145*, 1662, 1850 Zhou, J.............................. 219, 1525, 1561 Zhou, S ................................................. 179 Zhou, T ................................................. 332 Zhou, X .......... 538, 582, 764, 1848*, 2319 Zhou, Z ......................................... 210, 945 Zhu, B ................................ 354, 357*, 358 Zhu, H .............. 139, 143*, 465, 494, 1303 Zhu, J.................................................... 700 Zhu, K .................................................. 439 Zhu, P ................................................. 1053 Zhu, X .............................................. 1506* Zhu, Y............................................... 2264* Ziemek, D ............................................ 147 Zihlmann, C ......................................... 441 Zimmer, B ............................................ 868 Zimmerman, N ........................... 629, 1238 Zimmerman, R P ................................ 1303 Zimmermann, C ................................... 244 Zisch, A .............................................. 2169 Zitomer, N C ...................................... 1448 Ziv-Gal, A ........................................ 1219* Zmarowski, A ....................................... 195 Zoeller, R T ................................ 702, 2360 Zoeller, R............................................ 2608 Zoffmann, S ......................................... 316 Zokowski, K J .................................... 1922 Zong, Q ........................................ 528, 530 Zoni, S .................................................. 629 Zottola, M .......................................... 2046 Zsabo, M ............................................ 1269 Zuardi, A .............................................. 802 Zucker, R M ....................................... 2078 Zuehlke, U ............................................ 557 Zuno, F G ............................... 2088*, 2119 Zurita, J L ........................................... 2385 Zuscik, M ............................................. 293 Zverina, E A ......................................... 163 Zychowski, K ................................... 2228* SOT 2011 ANNUAL MEETING 605 AUTHOR INDEX
Page 1 and 2:
The Toxicologist Supplement to Toxi
Page 3 and 4:
The Toxicologist Supplement to Toxi
Page 5 and 6:
1 BIODEGRADABLE MATERIALS FOR TISSU
Page 7 and 8:
that genetic toxicology data are ge
Page 9 and 10:
well-orchestrated lung inflammation
Page 11 and 12:
scribed in the literature. We have
Page 13 and 14:
years ago). We will illustrate how
Page 15 and 16:
involved in the biodegradation proc
Page 17 and 18:
stem cells but rather a treatment i
Page 19 and 20:
additional compound showed agreemen
Page 21 and 22:
82 COMPARISON OF 3H-THYMIDINE INCOR
Page 23 and 24:
irritants. While in practice these
Page 25 and 26:
alleles are especially vulnerable t
Page 27 and 28:
109 CD4+ T CELL INTRINSIC TNF RECEP
Page 29 and 30:
118 TO STUDY THE SIGNAL TRANSDUCTIO
Page 31 and 32:
PAHs, such as dioxins, are prevalen
Page 33 and 34:
containing substituents and/or hydr
Page 35 and 36:
146 COMPUTATIONAL MODELING FOR QT P
Page 37 and 38:
suggest that the combination of too
Page 39 and 40:
164 TRANSLOCATOR PROTEIN (18 KDA) (
Page 41 and 42:
function as a metal binding protein
Page 43 and 44:
laboratory has demonstrated that NR
Page 45 and 46:
known. The aim of this study was to
Page 47 and 48:
from 5 to 28 days in duration) in e
Page 49 and 50:
positive cells, caspase-3 activatio
Page 51 and 52:
creased level in the 46 kDa preproe
Page 53 and 54:
invasiveness at concentrations repr
Page 55 and 56:
thracene (DMBA,50 μg in acetone, a
Page 57 and 58:
247 CO-CARCINOGENESIS OF N, N- DIET
Page 59 and 60:
sponds to the endosomal dsRNA that
Page 61 and 62:
ODD in both WT (maximum 177% of con
Page 63 and 64:
Lastly, using p53siRNA cells, p53 w
Page 65 and 66:
its receptor Mpl to exert its funct
Page 67 and 68:
294 LOW LEVEL OF LEAD CAN INDUCE PH
Page 69 and 70:
lunar surface presented potential h
Page 71 and 72:
lar about cellular export mechanism
Page 73 and 74:
DNA in the kidney medulla, grandula
Page 75 and 76:
5.00 and 7.50 mg/kg/day by oral gav
Page 77 and 78:
events and carcinogenesis. Here we
Page 79 and 80:
tinization of cells of the hair fol
Page 81 and 82:
358 CHARACTERIZATION OF GENOME-WIDE
Page 83 and 84:
RNAi were also performed to identif
Page 85 and 86:
376 A FUNCTIONAL CROSSTALK BETWEEN
Page 87 and 88:
UGT1A gene induction, while this re
Page 89 and 90:
tivity, specifically peroxisome pro
Page 91 and 92:
and cytotoxic effects; however, its
Page 93 and 94:
histone deacetylase that is necessa
Page 95 and 96:
ment. Paradoxically, buthionine sul
Page 97 and 98:
drug leflunomide and its major (A77
Page 99 and 100:
442 GENE EXPRESSION AND MORPHOLOGIC
Page 101 and 102:
451 INHIBITION OF THE MITOCHONDRIAL
Page 103 and 104:
460 SULFORAPHANE PREVENTS ACETAMINO
Page 105 and 106:
drophilic/lipophilic balance. Other
Page 107 and 108:
pharmacokinetic and toxicological p
Page 109 and 110:
489 USE OF ‘OMICS DATA TO IMPROVE
Page 111 and 112:
498 APPLICATION OF AGE-SPECIFIC ADJ
Page 113 and 114:
507 A DOSE VOLUME TOLERABILITY STUD
Page 115 and 116:
involved the use of an acute inflam
Page 117 and 118:
sorption in the gastrointestinal (G
Page 119 and 120:
(ABC) transporters actively transpo
Page 121 and 122:
545 BEHAVIORAL EFFECTS OF REPIN IN
Page 123 and 124:
a blood pressure phenotype that res
Page 125 and 126:
and inhalation exposure system that
Page 127 and 128:
and lethality associated with these
Page 129 and 130:
position, on vascular reactivity an
Page 131 and 132:
therefore more accurate and reprodu
Page 133 and 134:
commercial chrysotile product that
Page 135 and 136:
elative to their controls. ST-depre
Page 137 and 138:
ats. The majority of the studies fo
Page 139 and 140:
in the China Jintan Child Cohort St
Page 141 and 142:
corneum thickness, cellular epiderm
Page 143 and 144:
645 EVALUATION OF THE IN VITRO EPIS
Page 145 and 146:
654 TCDD ADSORBED ONTO NATURAL AND
Page 147 and 148:
tion revealed no test article-relat
Page 149 and 150:
671 INFLAMMATION AND TISSUE DAMAGE
Page 151 and 152:
model, ethanol was found to inhibit
Page 153 and 154:
689 ENHANCED SUPPRESSIVE FUNCTION O
Page 155 and 156:
NAC + LPS yielded different levels
Page 157 and 158:
707 LIFE-STAGE PBPK MODELS FOR MULT
Page 159 and 160:
downstream of the apical endpoint o
Page 161 and 162:
726 UPDATED ALUMINUM PHARMACOKINETI
Page 163 and 164:
global parameter sensitivity analys
Page 165 and 166:
and renal inflammation induced by 2
Page 167 and 168:
754 PLASMA, URINE, AND TISSUE CONCE
Page 169 and 170:
cently characterized transporter OA
Page 171 and 172:
exposure system was developed from
Page 173 and 174:
lood cell mass and decrease in urin
Page 175 and 176:
practical alternatives to MC in non
Page 177 and 178:
imals dosed with 167 mg/kg THU alon
Page 179 and 180:
and organ weights, clinical signs a
Page 181 and 182:
yet is induced in most bladder and
Page 183 and 184:
830 RISK ASSESSMENT OF THE SPILL: C
Page 185 and 186:
knowledgebase creation. Results are
Page 187 and 188:
852 UNDERSTANDING STRUCTURAL AND PH
Page 189 and 190:
for integrating epidemiology and an
Page 191 and 192:
motor activity, including age of th
Page 193 and 194:
y partial purification of urine (fr
Page 195 and 196:
pacity for self-renewal and may dif
Page 197 and 198:
sue. The depth of our analysis led
Page 199 and 200:
910 IMPLEMENTING CALIFORNIA’S GRE
Page 201 and 202:
concentrations in six tissues and b
Page 203 and 204:
934 THE FDA’S LIVER TOXICITY KNOW
Page 205 and 206:
943 GENOME-WIDE DNA METHYLATION DIF
Page 207 and 208:
membrane localization and subsequen
Page 209 and 210:
trols, respectively. Subtoxic and t
Page 211 and 212:
survival using both smoking regimes
Page 213 and 214:
as non-, weak, moderate, or strong
Page 215 and 216:
988 NNK-INDUCED CYTOKINE ALTERATION
Page 217 and 218:
group (one-way ANOVA, p90 % viabili
Page 219 and 220:
ered as an organ involved in xenobi
Page 221 and 222:
Transport of CPZ across the Caco-2
Page 223 and 224:
estrous cycle and sexual behavior d
Page 225 and 226:
mRNA expression levels. Collectivel
Page 227 and 228:
1043 THE EFFECTS OF ENDOCRINE DISRU
Page 229 and 230:
1052 MONO-2-ETHYLHEXYL PHTHALATE IN
Page 231 and 232:
Results: MC was variable within and
Page 233 and 234:
UtSMCs. Phosphorylation of FoxO1 wa
Page 235 and 236:
nonpregnant and pregnant diabetic m
Page 237 and 238:
1089 PFOA-INDUCED LIVER EFFECTS IN
Page 239 and 240:
events in the liver. AZD9056 was ev
Page 241 and 242:
The peppermint oil caused a concent
Page 243 and 244:
OA did not affect food consumption.
Page 245 and 246:
1126 PERSISTENT DEVELOPMENTAL ARYLH
Page 247 and 248:
1135 BACH2 BINDING TO Prdm1 AS A ME
Page 249 and 250:
The purpose of this project was to
Page 251 and 252:
one marrow. Since Chk1 is an attrac
Page 253 and 254:
1163 THE MRNA AND MIRNA PROFILE OF
Page 255 and 256:
have now compared the IC50 values b
Page 257 and 258:
1181 ELUCIDATION OF FACTORS DETERMI
Page 259 and 260:
enced by pre-exposure to cigarette
Page 261 and 262:
if abnormal PF was associated with
Page 263 and 264:
weight (P=0.016) and small for gest
Page 265 and 266:
portant cause of death, compared to
Page 267 and 268:
posure groups. However, the differe
Page 269 and 270:
Naphthalene is routinely analyzed i
Page 271 and 272:
1245 SEASONAL CHARACTERIZATION OF H
Page 273 and 274:
1255 URINARY T, T MUCONIC ACID LEVE
Page 275 and 276:
modating a reliable data evaluation
Page 277 and 278:
enzoquinone generate ROS and arylat
Page 279 and 280:
teins (e.g. C3, 4, and 5, APOB, VDB
Page 281 and 282:
1293 TRANSFORMING GROWTH FACTOR BET
Page 283 and 284:
mation was decreased to the same le
Page 285 and 286:
1312 EVALUATION OF THE SENSITIVITY
Page 287 and 288:
luted OFR and CRL. Culture media ex
Page 289 and 290:
urinary TCPy levels, blood and brai
Page 291 and 292:
activity. The dose-response curves
Page 293 and 294:
mice, each with 4 dose groups. One
Page 295 and 296:
exposure to both ATR and DACT has a
Page 297 and 298:
third tetratricopeptide repeats (TP
Page 299 and 300:
7d. 28d after TMT injury there was
Page 301 and 302:
subunits. Each cell type was treate
Page 303 and 304:
1394 COMPARATIVE EFFECTS OF METHYLM
Page 305 and 306:
1403 GENOTOXICITY AND PRE-NEOPLASTI
Page 307 and 308:
vated only in high-dose-treated ani
Page 309 and 310:
1421 DOSE-RESPONSE OF NAPHTHALENE-I
Page 311 and 312:
cisplatin; 1.2-, 1.9- and 2.9-fold
Page 313 and 314:
Day 11 and started to recover on Da
Page 315 and 316:
1448 DEVELOPMENT OF A METHOD FOR QU
Page 317 and 318:
1457 GLOBAL GENE PROFILING REVEALS
Page 319 and 320:
cluding mouse and human macrophage,
Page 321 and 322:
model of lung inflammation and host
Page 323 and 324:
1484 NANOTOXICOLOGY AND NANOHEALTH
Page 325 and 326:
throughput in vitro approach was us
Page 327 and 328:
1502 IMMUNOLOGICAL ASPECTS OF AN AN
Page 329 and 330:
(CIA) and the Streptococcal cell wa
Page 331 and 332:
sitizers were 100% concordant among
Page 333 and 334:
1530 MINIMAL RISK LEVELS FOR STYREN
Page 335 and 336:
ical groups in the field of regulat
Page 337 and 338:
vitro with this potentially insect-
Page 339 and 340:
their performance on toxicological
Page 341 and 342:
need for a better understanding of
Page 343 and 344:
1577 AN IN VITRO MODEL SYSTEM FOR A
Page 345 and 346:
gene expression post-transcriptiona
Page 347 and 348:
1595 GENE EXPRESSION PROFILE OF RAT
Page 349 and 350:
to confirm a hepatotoxic property o
Page 351 and 352:
1613 AN INVESTIGATION OF THE CLEARA
Page 353 and 354:
its nuclear translocation was reduc
Page 355 and 356:
were collected from TK animals at d
Page 357 and 358:
egulated targets were selected for
Page 359 and 360:
U/L after tetracycline. Minocycline
Page 361 and 362:
peri-pubertal FasL-/- mice show a d
Page 363 and 364:
showed similar levels of apoptosis
Page 365 and 366:
1676 TWO BIOMARKERS FOR EVALUATION
Page 367 and 368:
motifs selected. This system was ap
Page 369 and 370:
1693 VOC SERUM LEVELS IN THE GENERA
Page 371 and 372:
1702 DOES THE CLOCK MAKE THE POISON
Page 373 and 374:
those with high nickel content are
Page 375 and 376:
isk assessment. However, unique cha
Page 377 and 378:
model of APAP metabolism and glutat
Page 379 and 380:
logically & morphologically similar
Page 381 and 382:
posure, blood chemistry was analyze
Page 383 and 384:
elated to oxidative stress by measu
Page 385 and 386:
ostasis), but work is needed to tra
Page 387 and 388:
tokine products during carcinogenes
Page 389 and 390:
ways as chemical stressors and, the
Page 391 and 392:
toxicity of nanomaterials relates s
Page 393 and 394:
1815 MEASURING COMPOUND SELECTIVITY
Page 395 and 396:
1825 EFFECTS OF METABOLISM BY INTES
Page 397 and 398:
cyanoacetic acid increased 2-3 fold
Page 399 and 400:
1845 IS THE PROMISCUITY OF THE ARYL
Page 401 and 402:
crorarray analysis. RT-PCR results
Page 403 and 404:
are a family of phase-II biotransfo
Page 405 and 406:
ous labs. As a result of positive s
Page 407 and 408:
down the doses may produce more tox
Page 409 and 410:
spectively. Below 100 mg/l of gemfi
Page 411 and 412:
1900 GENERATION OF PRECISION CUT LI
Page 413 and 414:
iomarkers or observation of lesions
Page 415 and 416:
creased reticulocytes and lymphocyt
Page 417 and 418:
statistically significant interacti
Page 419 and 420:
monize sample preparation and analy
Page 421 and 422:
NPC and sinonasal cancer in neighbo
Page 423 and 424:
showed incidences of lung and nasal
Page 425 and 426:
utylbenzenes, exhibited most simila
Page 427 and 428:
1975 DIFFERENTIAL MODULATION OF CYP
Page 429 and 430:
organic As to MMA(V) and a lower ca
Page 431 and 432:
ole in invasion and metastasis of c
Page 433 and 434:
3T3-L1 cells to low-levels of arsen
Page 435 and 436:
2011 IDENTIFICATION OF A NOVEL VX M
Page 437 and 438:
This work was supported by Cooperat
Page 439 and 440:
2029 EFFICACY OF ENDOTRACHEAL ADMIN
Page 441 and 442:
Diazepam injections and its combina
Page 443 and 444:
2047 ESTERASE ACTIVITIES AND HEMOST
Page 445 and 446:
nanoparticle-induced toxicity progr
Page 447 and 448:
house, were iv infused into rats ov
Page 449 and 450:
een explored. This study investigat
Page 451 and 452:
croscopic analysis revealed that on
Page 453 and 454:
egg yolk collected from turtles inh
Page 455 and 456:
consistency of results in both expe
Page 457 and 458:
2111 CYTOCHROME P450 3A5 GENOTYPE I
Page 459 and 460:
esidues of organophosphates or thei
Page 461 and 462:
manganism. Recent work from our lab
Page 463 and 464:
Aβ1-40 in CSF and hippocampus in P
Page 465 and 466:
2147 CATALASE MANIPULATIONS MODIFY
Page 467 and 468:
ation based on real-world exposure
Page 469 and 470:
NPs. Aggregation of citrate-stabili
Page 471 and 472:
2175 THE ROLE OF SURFACE CHEMISTRY
Page 473 and 474:
seen rapid uptake in biological ima
Page 475 and 476:
effect on uterine weight or vaginal
Page 477 and 478:
dicating widespread exposure. While
Page 479 and 480:
components into the liver parenchym
Page 481 and 482:
2223 ISOLATION AND DETECTION OF RIC
Page 483 and 484:
stored (-20 celsius degree). The co
Page 485 and 486:
2241 DDA, A BIOMARKER FOR ENVIRONME
Page 487 and 488:
2249 INTERACTION BETWEEN DIETARY SE
Page 489 and 490:
2258 PHARMACOKINETICS, EXCRETION BA
Page 491 and 492:
2267 SENSITIVE AND SPECIFIC FLUORES
Page 493 and 494:
2276 METABOLISM AND DISPOSITION OF
Page 495 and 496:
ment of hypertension in companion a
Page 497 and 498:
for the propyl series can be used f
Page 499 and 500:
2304 IN VITRO EXPOSURE AND EVALUATI
Page 501 and 502:
2313 THE SYNERGISTIC EFFECT OF SODI
Page 503 and 504:
genes that play a crucial role in M
Page 505 and 506:
2330 THE ROLE OF TRANSFORMING GROWT
Page 507 and 508:
ined following up to 96 h continuou
Page 509 and 510:
effect doses obtained with the rat
Page 511 and 512:
diated transcriptional response of
Page 513 and 514:
docrine disruptor activities of EDC
Page 515 and 516:
individuals. Week 6 results were qu
Page 517 and 518:
functionality of photosystem II and
Page 519 and 520:
wild mice (Mus musculus) from areas
Page 521 and 522:
2406 TOXICITY AND BIOACCUMULATION O
Page 523 and 524:
Isocitric acid is the acid in the h
Page 525 and 526:
2425 EFFECTS OF FUMONISINS IN ETHAN
Page 527 and 528:
centration(μg/g) were: 5.1-95.3; 2
Page 529 and 530:
2445 AUTOPHAGY IN DEVELOPMENT: A LI
Page 531 and 532:
sures to inhaled Mn in dust. Nevert
Page 533 and 534:
2466 CRITICAL EVALUATION OF ANIMAL
Page 535 and 536:
elationships predict that resting r
Page 537 and 538:
2489 COMPARATIVE TOXICITY OF BIODIE
Page 539 and 540:
2497 TRANSCRIPTIONAL REGULATION OF
Page 541 and 542:
2506 TOXICOLOGICAL CONSIDERATIONS O
Page 543 and 544:
launched with the aim of developing
Page 545 and 546:
forms mRNA expression levels were a
Page 547 and 548:
2534 CUTANEOUS WOUND HEALING IN THE
Page 549 and 550:
wells (0, 1, 5, 10, 25, 50, 100, an
Page 551 and 552:
2553 AN ORGANOTYPIC MICROLIVER PLAT
Page 553 and 554:
serum-free media. At 24 hrs, the gr
Page 555 and 556:
2572 INCREASED ARSENIC BIOACCESSIBI
Page 557 and 558: nology to develop improved methods.
Page 559 and 560: tuna, swordfish, or mako shark (3.5
Page 561 and 562: nificantly reduce circulating thyro
Page 563 and 564: grouped into 9 observation periods
Page 565 and 566: histopathological or biochemical ev
Page 567 and 568: exhibited a hyperactive phenotype,
Page 569 and 570: the search of effective drugs for e
Page 571 and 572: 2644 COVALENT BINDING OF 14 C 2-MET
Page 573 and 574: aries targeting all transcription f
Page 575 and 576: (p 9 weeks) and CSC phenotype acqui
Page 577 and 578: 2673 IMMUNE-MEDIATED VASCULAR INJUR
Page 579 and 580: for risk identification and charact
Page 581 and 582: to control toxicant delivery in tob
Page 583 and 584: Author Index (Continued) The numera
Page 607: Author Index (Continued) The numera
Page 611 and 612: Keyword Index (Continued) Arsenite
Page 613 and 614: Keyword Index (Continued) Covalent
Page 615 and 616: Keyword Index (Continued) flow cyto
Page 617 and 618: Keyword Index (Continued) innate im
Page 619 and 620: Keyword Index (Continued) nanoparti
Page 621 and 622: Keyword Index (Continued) preservat
Page 623 and 624: Keyword Index (Continued) Thrombocy
Page 625 and 626: Toxicological Sciences The Official
show all

The Toxicologist - Society of Toxicology

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?